It is strange. But Venus is right in that off-labeling and eventually getting approval is way more lucrative than starting from scratch to develop something new. My question is why even in a research setting, in academia, nobody asked themselves this question.

To put a positive spin on it, I am glad to have such an enigmatic condition that nobody has a clue